[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367034-105":59,"doc-detail-367034-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lncrna-chaf1b-2-contributes-to-the-tumorigenesis-of-gastric-cancer-by-activating-the-wnt-catenin-pathway","lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway","","lnc-CHAF1B-2, a newly discovered long noncoding RNA, was studied for its function in gastric cancer using bioinformatics analysis of TCGA gastric RNA-seq data and validation by in vivo and in vitro experiments. The study found lnc-CHAF1B-2 upregulated in gastric cancer tissues and positively associated with distant metastasis, worsening prognosis and survival. Mechanistically, lnc-CHAF1B-2 enhances proliferation, invasion, and migration while suppressing apoptosis by activating the Wnt/β-catenin signaling pathway.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lncrna-chaf1b-2-contributes-to-the-tumorigenesis-of-gastric-cancer-by-activating-the-wnt-catenin-pathway/367034/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lncrna-chaf1b-2-contributes-to-the-tumorigenesis-of-gastric-cancer-by-activating-the-wnt-catenin-pathway/367034.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this research on lnc-CHAF1B-2?","Question",{"text":112,"@type":113},"The research investigates how lnc-CHAF1B-2 contributes to gastric cancer development and patient outcomes, and identifies the signaling pathway involved.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was lnc-CHAF1B-2 studied and validated?",{"text":117,"@type":113},"Expression patterns were examined using TCGA-based bioinformatics from gastric cancer RNA-seq data, then validated with multiple in vivo and in vitro assays including proliferation and invasion-related tests and western blotting.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does lnc-CHAF1B-2 play in gastric cancer cell behavior and apoptosis?",{"text":121,"@type":113},"lnc-CHAF1B-2 increases proliferation, invasion, and migration while inhibiting apoptosis in both in vitro and in vivo settings.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367034,1790227393,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nlncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway  \nShao-Qi Tian1, Jun-Jie Shen2, Dao-Ping Sun3􀀍 & Wen-Ming Chen4􀀍  \nLnc-CHAF1B-2, a newly discovered long noncoding RNA (lncRNA), plays a significant role in the evolution and prognosis of diverse neoplasms. However, its role in the development of gastric cancer isnot yet fully understood. Using bioinformatics analysis of gastric cancer RNA-seq data from The Cancer Genome Atlas (TCGA) database, we investigated the expression of lnc-CHAF1B-2 in gastric carcinoma and its associated molecular signalling pathways. Verification through an array of in vivo and in vitro experiments—namely, EdU incorporation, flow cytometry, trans-well migration and invasion assays, subcutaneous tumour formation in nude mice, and western blot analysis—was conducted. We revealed notable upregulation of lnc-CHAF1B-2 in gastric cancer tissues. Furthermore, a positive correlation was detected between lnc-CHAF1B-2 levels and the occurrence of distant metastases in patients, which was inversely related to their prognostic outlook and survival rates. Moreover, our findings confirmed that lnc-CHAF1B-2 enhanced the proliferation, invasion, and migration of gastric cancer cells while inhibiting apoptosis both in vitro and in vivo. Mechanistically, lnc-CHAF1B-2 promoted the progression of gastric cancer through activating the Wnt/β-catenin signalling pathway. Thus, lnc-CHAF1B-2 and its regulation oftheWnt/β-catenin signalling pathway have emerged as prospective therapeutic targets in gastric cancer management.  \nKeywords Gastric cancer, LncRNA, lnc-CHAF1B-2, Wnt/β-catenin signalling pathway  \nGastric cancer, a common malignancy, originates from the epithelial lining of the stomach and comprises 95% of all malignant gastric tumours1. Gastric cancer is one of the leading causes of death worldwide, and its high incidence and mortality rates pose a significant threat to human health and life. According to reports, the global incidence of cancer is increasing by approximately 20 million cases annually, with gastric cancer accounting for approximately 4.9% of the total. The number of cancer-related deaths is estimated to be approximately 9.7 million cases per year, of which gastric cancer accounts for 6.8%2,3. The incidence and mortality rates of gastric cancer rank fifth globally among all cancer types, making it a significant threat to human health4. The underlying mechanisms governing the emergence and progression of gastric cancer remain incompletely understood. Research indicates that the development of gastric cancer is not attributable to a single factor but rather to an intricate process involving the interplay between genetic determinants and environmental influences associated with geographical setting, dietary practices, Helicobacter pylori infection, precancerous conditions, heredity, and genetic constituents5,6. Despite the exploration of numerous novel diagnostic and therapeutic approaches in recent years, the dismal prognosis of patients with gastric cancer persists owing to its high recurrence and metastasis rates. As a burgeoning approach in the field of oncology in recent years, targeted therapy has revolutionized the treatment of gastric cancer because of its precision in targeting specific molecular markers6–8. Delving into the molecular and metabolic pathways in gastric cancer cells will aid in identifying pivotal molecules closely associated with the occurrence and progression of gastric cancer, unveiling novel therapeutic targets, and comprehensively enhancing the diagnostic and therapeutic efficacy for gastric cancer.  \nIn recent years, rapid advancements in sequencing technologies and bioinformatics have provided multifaceted means and approaches to delve into the molecular mechanisms underlying the pathogenesis and  \n1Department of Oncology, Jining Hospital of","cbCaiokxhzHwEAjz","https://ap.wps.com/l/cbCaiokxhzHwEAjz","pdf",2393882,11,"English","# Background\n## Gastric cancer burden and research need\n## Targeted therapy and molecular pathway exploration\n# lncRNAs and study rationale\n## Characteristics and roles of lncRNAs\n## CHAF1B-2 as a potential biomarker\n# Study design and methods\n## TCGA bioinformatics analysis\n## In vivo and in vitro validation assays\n# Results\n## Upregulation in tissues and clinical correlation\n## Effects on tumor cell behaviors\n# Mechanism and implications\n## Wnt/β-catenin pathway activation\n## Therapeutic target potential","[{\"question\":\"What is the main focus of this research on lnc-CHAF1B-2?\",\"answer\":\"The research investigates how lnc-CHAF1B-2 contributes to gastric cancer development and patient outcomes, and identifies the signaling pathway involved.\"},{\"question\":\"How was lnc-CHAF1B-2 studied and validated?\",\"answer\":\"Expression patterns were examined using TCGA-based bioinformatics from gastric cancer RNA-seq data, then validated with multiple in vivo and in vitro assays including proliferation and invasion-related tests and western blotting.\"},{\"question\":\"What role does lnc-CHAF1B-2 play in gastric cancer cell behavior and apoptosis?\",\"answer\":\"lnc-CHAF1B-2 increases proliferation, invasion, and migration while inhibiting apoptosis in both in vitro and in vivo settings.\"}]","lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway | PDF",1790168913,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/509f51d523b373f18a31486de425b358.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/206781040fbaf1453389c5ffc18ed8b3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/300c4e15f6dec552f50260cb7273a0ba.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1ceebc112dc6405a46192378b571754.webp",980,1287]